Skip to content

Effect of safflower oral product in treatment of metabolic syndrome

Evaluation of oral product of Carthamus tinctorius effect on cardiovascular risk factors among metabolic syndrome patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180515039673N1
Enrollment
90
Registered
2018-08-01
Start date
2018-06-10
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome includes pre-diabetes, dyslipidemia, overweight and obesity and hypertension. Metabolic syndrome

Interventions

Intervention 1: Intervention group: One gram capsules made by Barij-Essence Pharmaceutical Company contains safflower oil, which 8 of them will be given daily with 6-hour intervals for next 12 weeks.

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Informed and written consent for participation in the study / Body mass index (BMI) above 27 / Having three signs of the five characteristics of the metabolic syndrome based on the definitions of NCEP-ATPIII

Exclusion criteria

Exclusion criteria: Use of extra- protocol treatments / Use of drugs associated with treatment of metabolic syndrome in the past month / Safflower allergy /positive history of kidney, liver, cancer, thyroid and/or coagulation disease / pregnancy and/or lactation / smoking, alcohol and/or substance abuse / Taking anti-platelet and anticoagulant drugs (such as Aspirin, Clopidogrel, Warfarin, etc.)

Design outcomes

Primary

MeasureTime frame
Percentage of people with hypertension. Timepoint: Measuring hypertension at the beginning of the study (before the intervention) and 1, 2 and 3 months after the onset of intervention. Method of measurement: Automated sphygmomanometer.

Secondary

MeasureTime frame
Composition of body components. Timepoint: Measurement at the beginning of the study (before the intervention) and 12 weeks after intervention. Method of measurement: Medical body Composition Analyzer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaede ruyvaran

Shiraz University of Medical Sciences

ruyvaran@sums.ac.ir+98 71 3234 5145

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026